Objective
The emergence of bacterial resistance has significantly underscored the importance of the discovery of novel classes of antibiotics. The common occurrence of multiple-drug resistant microbes, particularly in hospital settings, is cause for serious clinical concerns. Additionally, the existence of large cohorts of immune compromised patients and the need to utilise anti-infective agents prophylactic ally in their lifetime therapy compound the problem. Finally, the potential activities of dysfunctional nations and their disciples of death are chilling additions to the threat to the welfare of mankind. In 2002 Pfizer scientists reported the isolation of CJ-15, 696 and seven related fur pyridine antibiotics from the fermentation broth of the fungus Cladobotrywn varmint CL 12284. CJ-15, 696 showed modest activities against various Gram-positive bacteria including some drug resistant strains such as Staphylococcus aurous 01 A1 105, Staphylococcus progenies 02C1068, Staphylococcus pneumonia 02J1095 and Entercoccus faecal is 03A1069. S: pneumonia is frequently the causative agent for upper respiratory tract infections and is rapidly acquiring multi.
- Drug resistance. Research will focus on the development of a new strategy for the total synthesis of CJ-15, 696. This will be amenable for the concise synthesis of fur pyridines as a general class and for the elaboration of analogues of the natural product to probe antibacterial activity. A concise and flexible total synthesis of CJ-15, 696 should make available a family of fur pyridine derivatives of potential value as novel antibiotics. The synthesis involves a new ring expansion process for the conversion of N-arenesulfonyl-ÿ-lactam derivatives, by reaction with emulates derived from y-lactones, into fur pyridine compounds. A library of analogues of the natural product will be prepared by parallel synthesis by use of arrays of ÿ-Iota and y-lactones precursors.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine pneumology
- natural sciences biological sciences microbiology mycology
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antibiotics
- engineering and technology industrial biotechnology bioprocessing technologies fermentation
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-5
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
LONDON
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.